by Stacey Johnson | Dec 16, 2022
Back in 2014, Selena Gomez was diagnosed with lupus. The singer and actress has been public about getting chemotherapy to treat her condition, and her kidney transplant. The autoimmune disease causes the immune system to attack the body’s tissues and organs....
by Stacey Johnson | Dec 2, 2022
The other day someone asked me if I was all ready for Christmas. It wasn’t even December yet! Bah humbug. I don’t have a tree yet, nor am I ready to deal with decorating my house. The only thing I start doing before December is shopping. Not that I’m finished, but I’m...
by Stacey Johnson | Nov 25, 2022
If manufacturing is the gatekeeper to success in the cell and gene therapy space, it’s not surprising that the topic regularly comes up when industry leaders come together to discuss the future or to tackle the challenges we face in commercializing cell and gene...
by Stacey Johnson | Nov 4, 2022
Despite valiant efforts by countless people and organizations, misinformation and a lack of public trust in science continue to be prevalent themes in 2022. Day two of the Till & McCulloch Meetings in Vancouver kicked off with an informative plenary exploring...
by Stacey Johnson | Sep 30, 2022
After returning from CellCAN’s 2022 Strategic Forum in Ottawa, Ontario, where Canada’s cell and gene therapy biomanufacturing community came together to share information and network, it is clear that the country’s biomanufacturing landscape is improving. As I and...
by Stacey Johnson | Sep 9, 2022
Now is a fantastic time to be an undergraduate student, graduate student or postdoc (sometimes referred to as trainees or highly qualified personnel) interested in regenerative medicine. In addition to the education you receive in the classroom or lab, your university...
Comments